Abilita Therapeutics
PrivateLast Round
Grant
Sep 15, 2023
Total Funding Raised
$1.43M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Abilita Therapeutics is a biotechnology company that discovers and develops therapeutics targeting challenging membrane proteins like GPCRs, ion channels, and transporters.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abilita Therapeutics Comparables
Compare Abilita Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salipro Biotech AB | 86% | |
| Confo Therapeutics | 86% | |
| Maxion Therapeutics | 84% | |
Abilita Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2023 | ||||
| VC Round | Feb 21, 2023 | ||||
| Grant | Sep 1, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Sep 20, 2016 |
Abilita Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Two Bear Capital | VC Round |
| National Institute on Aging | Grant |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors increased 65% MoM.
Abilita Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abilita Therapeutics's valuation, stock price, and market status.